Successful Outcome of Disseminated Fusarium Infection with Skin Localization Treated with Voriconazole and Amphotericin B-Lipid Complex in a Patient with Acute Leukemia-Reference-Cited by-同舟云学术

Successful Outcome of Disseminated Fusarium Infection with Skin Localization Treated with Voriconazole and Amphotericin B-Lipid Complex in a Patient with Acute Leukemia

Published:2003-10 Issue:10 Volume:41 Page:4898-4900
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Durand-Joly Isabelle¹²,Alfandari Serge³,Benchikh Zinnédine¹,Rodrigue Marion¹,Espinel-Ingroff Ana⁴,Catteau Benoit⁵,Cordevant Christophe²,Camus Daniel¹²,Dei-Cas Eduardo¹²,Bauters Francis⁶,Delhaes Laurence¹²,De Botton Stéphane⁶

Affiliation:

1. Parasitologie-Mycologie, Faculté de Médecine

2. EA-3609-IFR17, Institut Pasteur de Lille, Lille

3. Maladies Infectieuses, Tourcoing, France

4. Medical Mycology Research Laboratory, Medical College of Virginia, Richmond, Virginia

5. Service de Dermatologie

6. Service des Maladies du Sang, CHRU de Lille

Abstract

ABSTRACT A disseminated Fusarium oxysporum infection with skin localization was diagnosed in a woman with a relapse of B-acute leukemia during induction chemotherapy. The infection was refractory to amphotericin B-lipid complex alone but responded successfully when voriconazole was added.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.41.10.4898-4900.2003

Reference16 articles.

1. Anaissie, E., H. Kantarjian, P. Jones, B. Barlogie, M. Luna, G. Lopez-Berestein, and G. P. Bodey. 1986. Fusarium. A newly recognized fungal pathogen in immunosuppressed patients. Cancer57:2141-2145.

2. Microdilution Susceptibility Testing of Amphotericin B, Itraconazole, and Voriconazole against Clinical Isolates of Aspergillus and Fusarium Species

3. Boutati, E. I., and E. J. Anaissie. 1997. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. Blood90:999-1008.

4. Dei-Cas, E., L. Dujardin, M. E. Ribeiro Pinto, F. Ajana, J. Fruit, D. Poulain, D. Camus, and A. Vernes. 1991. Kinetic study of antifungal activity of amphotericin B, 5-fluorocytosine and ketoconazole against clinical yeast isolates using liquid-phase turbidimetry. Mycoses34:167-172.

5. Denning, D. W., P. Ribaud, N. Milpied, D. Caillot, R. Herbrecht, E. Thiel, A. Haas, M. Ruhnke, and H. Lode. 2002. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin. Infect. Dis.34:563-571.

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on therapeutic approaches for invasive fungal infections in adults;Therapeutic Advances in Infectious Disease;2024-01

2. Fusariosis in Mexico: A 10-year retrospective series;Medical Mycology;2023-11-07

3. Fusariosis en pacientes con cáncer: serie de 13 casos y revisión de la literatura;Biomédica;2023-08-31

4. Evolution of antifungals for invasive mold infections in immunocompromised hosts, then and now;Expert Review of Anti-infective Therapy;2023-05-01

5. Mucorales/Fusarium Mixed Infection in Hematologic Patient with COVID-19 Complications: An Unfortunate Combination;Pathogens;2023-02-12